Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Mallinckrodt
Baxter
Express Scripts
Colorcon
McKinsey
Queensland Health
Covington
Boehringer Ingelheim

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087589

« Back to Dashboard

NDA 087589 describes METHOCARBAMOL, which is a drug marketed by Marsam Pharms Llc, Watson Labs, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Luitpold Pharms Inc, Monterey Pharms Llc, Mylan Institutional, Navinta Llc, Renaissance Ssa Llc, Sagent Pharms, Somerset Theraps Llc, Able, Am Therap, Ascot, Austarpharma Llc, Beximco Pharms Usa, Clonmel Hlthcare, Dbl Pharms, Fosun Pharma, Granules India Ltd, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Mylan, Nylos, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Vintage Pharms, Mcneil, Par Pharm, and Stevens J, and is included in seventy NDAs. It is available from fifty-six suppliers. Additional details are available on the METHOCARBAMOL profile page.

The generic ingredient in METHOCARBAMOL is aspirin; methocarbamol. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for 087589
Tradename:METHOCARBAMOL
Applicant:Superpharm
Ingredient:methocarbamol
Patents:0
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 087589

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Jan 22, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Baxter
Chubb
AstraZeneca
Queensland Health
UBS
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.